| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.663 | 0.009 | 0.663 | 5 Hydroxytryptamine release stimulant | |||
| 0.613 | 0.007 | 0.613 | Antimitotic | |||
| 0.613 | 0.025 | 0.613 | Cyclophilin D inhibitor | 0.235 0.229 CID_154699917 | ||
| 0.622 | 0.044 | 0.622 | Apoptosis agonist | 0.272 0.193 CID_154699917 | ||
| 0.624 | 0.047 | 0.624 | Antiinflammatory | |||
| 0.548 | 0.004 | 0.548 | Antineoplastic antibiotic | |||
| 0.549 | 0.014 | 0.549 | Caspase 3 stimulant | |||
| 0.569 | 0.041 | 0.569 | Caspase 9 stimulant | |||
| 0.524 | 0.022 | 0.537 | Histamine release inhibitor | 0.537 0.019 CID_154699917 | CID_154699917 | |
| 0.522 | 0.027 | 0.522 | Immunosuppressant | 0.339 0.093 CID_154699917 | ||
| 0.494 | 0.027 | 0.494 | GABA C receptor rho-3 antagonist | |||
| 0.48 | 0.017 | 0.48 | Nitric oxide antagonist | 0.143 0.102 CID_154699917 | ||
| 0.48 | 0.022 | 0.48 | Antioxidant | 0.323 0.054 CID_154699917 | ||
| 0.477 | 0.04 | 0.477 | 5 Hydroxytryptamine release inhibitor | |||
| 0.454 | 0.019 | 0.454 | DNA damaging | 0.174 0.14 CID_154699917 | ||
| 0.441 | 0.022 | 0.441 | Hypoglycemic | 0.24 0.083 CID_154699917 | ||
| 0.426 | 0.01 | 0.426 | 5 Hydroxytryptamine uptake stimulant | 0.189 0.175 CID_154699917 | ||
| 0.438 | 0.023 | 0.438 | Antiamyloidogenic | 0.273 0.061 CID_154699917 | ||
| 0.418 | 0.012 | 0.418 | Hepatoprotectant | 0.386 0.014 CID_154699917 | ||
| 0.454 | 0.055 | 0.48 | Antibacterial | 0.48 0.047 CID_154699917 | CID_154699917 | |
| 0.421 | 0.025 | 0.421 | Free radical scavenger | 0.277 0.058 CID_154699917 | ||
| 0.432 | 0.044 | 0.432 | Cholesterol antagonist | |||
| 0.419 | 0.044 | 0.419 | Aldehyde oxidase inhibitor | |||
| 0.376 | 0.007 | 0.376 | UDP-glucose 4-epimerase inhibitor | |||
| 0.437 | 0.07 | 0.437 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.373 | 0.01 | 0.373 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.406 | 0.048 | 0.421 | Antithrombotic | 0.421 0.044 CID_154699917 | CID_154699917 | |
| 0.355 | 0.016 | 0.355 | Melanin inhibitor | |||
| 0.381 | 0.044 | 0.492 | Apoptosis antagonist | 0.492 0.021 CID_154699917 | CID_154699917 | |
| 0.363 | 0.028 | 0.363 | DNA synthesis inhibitor | |||
| 0.354 | 0.023 | 0.354 | RNA-directed DNA polymerase inhibitor | |||
| 0.345 | 0.029 | 0.627 | Peroxidase inhibitor | 0.627 0.004 CID_154699917 | CID_154699917 | |
| 0.364 | 0.049 | 0.364 | Vasodilator, coronary | |||
| 0.306 | 0.01 | 0.306 | Nitric-oxide synthase stimulant | |||
| 0.333 | 0.038 | 0.333 | Amyloid beta aggregation inhibitor | 0.184 0.087 CID_154699917 | ||
| 0.337 | 0.049 | 0.337 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.342 | 0.055 | 0.342 | Calcium channel activator | |||
| 0.328 | 0.044 | 0.328 | Tumour necrosis factor alpha release inhibitor | 0.169 0.135 CID_154699917 | ||
| 0.317 | 0.044 | 0.317 | Hypolipemic | |||
| 0.292 | 0.02 | 0.292 | Neurotrophic factor enhancer | |||
| 0.348 | 0.078 | 0.348 | Transcription factor NF kappa B inhibitor | 0.318 0.086 CID_154699917 | ||
| 0.28 | 0.011 | 0.28 | Cystathionine beta-synthase inhibitor | |||
| 0.275 | 0.007 | 0.275 | Beta amyloid protein antagonist | |||
| 0.288 | 0.02 | 0.288 | Amylase inhibitor | |||
| 0.289 | 0.022 | 0.289 | Interferon gamma antagonist | |||
| 0.268 | 0.005 | 0.268 | Electron transport complex I inhibitor | |||
| 0.288 | 0.029 | 0.301 | Peptidyltransferase inhibitor | 0.301 0.024 CID_154699917 | CID_154699917 | |
| 0.265 | 0.008 | 0.273 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.273 0.008 CID_154699917 | CID_154699917 | |
| 0.334 | 0.081 | 0.334 | Vasodilator, peripheral | |||
| 0.263 | 0.016 | 0.263 | Cholesterol synthesis inhibitor | |||
| 0.266 | 0.022 | 0.266 | Topoisomerase II inhibitor | |||
| 0.283 | 0.042 | 0.283 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.247 | 0.009 | 0.247 | Microtubule formation inhibitor | 0.117 0.064 CID_154699917 | ||
| 0.253 | 0.016 | 0.253 | Topoisomerase I inhibitor | |||
| 0.251 | 0.026 | 0.251 | NOS3 expression enhancer | |||
| 0.23 | 0.012 | 0.23 | Carbonic anhydrase III inhibitor | 0.123 0.042 CID_154699917 | ||
| 0.239 | 0.026 | 0.239 | Succinate dehydrogenase inhibitor | |||
| 0.261 | 0.054 | 0.261 | Psychostimulant | |||
| 0.253 | 0.049 | 0.253 | Anesthetic general | |||
| 0.216 | 0.016 | 0.216 | Interleukin 1b antagonist | |||
| 0.263 | 0.065 | 0.263 | Gastrin inhibitor | 0.235 0.098 CID_154699917 | ||
| 0.216 | 0.019 | 0.216 | Ferrochelatase inhibitor | |||
| 0.196 | 0.004 | 0.196 | Ca2+-transporting ATPase inhibitor | |||
| 0.214 | 0.023 | 0.214 | Alkylator | 0.162 0.04 CID_154699917 | ||
| 0.199 | 0.011 | 0.199 | Creatine kinase inhibitor | |||
| 0.215 | 0.027 | 0.215 | ATPase inhibitor | |||
| 0.191 | 0.005 | 0.191 | Leukotriene synthesis inhibitor | |||
| 0.247 | 0.065 | 0.247 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.195 | 0.015 | 0.195 | Carbonic anhydrase XIII inhibitor | |||
| 0.218 | 0.038 | 0.218 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.207 | 0.027 | 0.207 | Arachidonic acid antagonist | |||
| 0.209 | 0.036 | 0.209 | Interleukin 6 antagonist | |||
| 0.188 | 0.021 | 0.188 | Carbonic anhydrase XV inhibitor | |||
| 0.19 | 0.023 | 0.581 | Expectorant | 0.581 0.003 CID_154699917 | CID_154699917 | |
| 0.195 | 0.034 | 0.195 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.178 | 0.019 | 0.491 | Mucolytic | 0.491 0.002 CID_154699917 | CID_154699917 | |
| 0.192 | 0.034 | 0.192 | GABA C receptor rho-2 antagonist | |||
| 0.171 | 0.014 | 0.171 | NADH dehydrogenase inhibitor | |||
| 0.171 | 0.015 | 0.171 | Phosphofructokinase-1 inhibitor | |||
| 0.214 | 0.062 | 0.214 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.192 | 0.039 | 0.192 | Tubulin antagonist | |||
| 0.238 | 0.088 | 0.25 | Interleukin agonist | 0.25 0.079 CID_154699917 | CID_154699917 | |
| 0.163 | 0.017 | 0.163 | Triose-phosphate isomerase inhibitor | |||
| 0.301 | 0.157 | 0.301 | Calcium channel L-type activator | |||
| 0.181 | 0.038 | 0.181 | Monophenol monooxygenase inhibitor | 0.162 0.043 CID_154699917 | ||
| 0.164 | 0.022 | 0.164 | Adenylate kinase inhibitor | 0.142 0.03 CID_154699917 | ||
| 0.179 | 0.038 | 0.179 | Neurotrophic factor | 0.115 0.103 CID_154699917 | ||
| 0.162 | 0.024 | 0.162 | GABA C receptor antagonist | |||
| 0.185 | 0.047 | 0.185 | Protein kinase stimulant | |||
| 0.17 | 0.033 | 0.17 | Cyclooxygenase 3 inhibitor | 0.148 0.05 CID_154699917 | ||
| 0.205 | 0.068 | 0.264 | Insulin sensitizer | 0.264 0.027 CID_154699917 | CID_154699917 | |
| 0.171 | 0.034 | 0.171 | Adenylate cyclase stimulant | |||
| 0.179 | 0.043 | 0.179 | Interleukin 1 antagonist | |||
| 0.149 | 0.017 | 0.149 | CYP2A6 inhibitor | |||
| 0.166 | 0.036 | 0.166 | DNA intercalator | |||
| 0.138 | 0.009 | 0.138 | Glycine receptor agonist | |||
| 0.144 | 0.016 | 0.144 | Dopamine agonist | |||
| 0.209 | 0.09 | 0.412 | Angiogenesis stimulant | 0.412 0.02 CID_154699917 | CID_154699917 | |
| 0.15 | 0.032 | 0.15 | Alpha 2c adrenoreceptor antagonist | |||
| 0.144 | 0.028 | 0.144 | Beta glucuronidase inhibitor | |||
| 0.13 | 0.013 | 0.13 | Glycine receptor antagonist | |||
| 0.125 | 0.009 | 0.125 | Protein 50S ribosomal subunit inhibitor | |||
| 0.222 | 0.108 | 0.584 | Immunostimulant | 0.584 0.019 CID_154699917 | CID_154699917 | |
| 0.137 | 0.025 | 0.137 | Anabolic | |||
| 0.131 | 0.02 | 0.248 | Glutamate dehydrogenase inhibitor | 0.248 0.007 CID_154699917 | CID_154699917 | |
| 0.154 | 0.043 | 0.154 | Cathepsin H inhibitor | |||
| 0.143 | 0.037 | 0.143 | GABA C receptor agonist | |||
| 0.144 | 0.04 | 0.144 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.22 | 0.116 | 0.22 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.14 | 0.038 | 0.14 | Photosensitizer | |||
| 0.158 | 0.058 | 0.161 | Cell wall synthesis inhibitor | 0.161 0.055 CID_154699917 | CID_154699917 | |
| 0.138 | 0.039 | 0.138 | Xanthine oxidase inhibitor | |||
| 0.136 | 0.037 | 0.136 | AMP-activated protein kinase stimulant | |||
| 0.129 | 0.033 | 0.129 | GABA C receptor rho-1 antagonist | |||
| 0.115 | 0.019 | 0.115 | Na+ K+ transporting ATPase inhibitor | |||
| 0.108 | 0.013 | 0.108 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.11 | 0.016 | 0.11 | Biliverdin reductase inhibitor | |||
| 0.1 | 0.007 | 0.1 | MDM2 inhibitor | |||
| 0.144 | 0.051 | 0.144 | Aldehyde dehydrogenase inhibitor | 0.143 0.052 CID_154699917 | ||
| 0.101 | 0.01 | 0.101 | Glutamate (mGluR7) antagonist | |||
| 0.12 | 0.03 | 0.12 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.107 | 0.017 | 0.107 | Toll-Like receptor 7 antagonist | |||
| 0.115 | 0.026 | 0.115 | Glutamate release inhibitor | |||
| 0.114 | 0.027 | 0.476 | Histidine decarboxylase inhibitor | 0.476 0.003 CID_154699917 | CID_154699917 | |
| 0.116 | 0.031 | 0.116 | Carbonic anhydrase VI inhibitor | |||
| 0.096 | 0.011 | 0.096 | Exportin-1 inhibitor | |||
| 0.123 | 0.038 | 0.123 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.152 | 0.067 | 0.152 | Lipid peroxidase inhibitor | 0.123 0.09 CID_154699917 | ||
| 0.201 | 0.117 | 0.201 | Superoxide dismutase inhibitor | 0.184 0.136 CID_154699917 | ||
| 0.137 | 0.054 | 0.137 | Adenylate cyclase inhibitor | |||
| 0.126 | 0.045 | 0.126 | Estrogen antagonist | |||
| 0.137 | 0.057 | 0.137 | DNA polymerase I inhibitor | |||
| 0.106 | 0.026 | 0.106 | mTOR complex 2 inhibitor | |||
| 0.083 | 0.004 | 0.083 | Dopamine D1 agonist | |||
| 0.146 | 0.066 | 0.146 | Toll-Like receptor 9 antagonist | |||
| 0.116 | 0.037 | 0.116 | Estrogen receptor beta antagonist | |||
| 0.097 | 0.018 | 0.097 | Purinergic P2X1 antagonist | |||
| 0.111 | 0.032 | 0.111 | Alpha 2a adrenoreceptor antagonist | |||
| 0.104 | 0.026 | 0.13 | Selectin antagonist | 0.13 0.02 CID_154699917 | CID_154699917 | |
| 0.089 | 0.011 | 0.089 | Transcription factor RelA inhibitor | |||
| 0.09 | 0.013 | 0.09 | Estrogen receptor beta agonist | |||
| 0.092 | 0.018 | 0.092 | Carbonic anhydrase VB inhibitor | |||
| 0.197 | 0.122 | 0.197 | Spasmolytic | |||
| 0.099 | 0.026 | 0.099 | Phenylalanine 4-hydroxylase inhibitor | 0.095 0.028 CID_154699917 | ||
| 0.089 | 0.016 | 0.089 | Glutamate (mGluR6) antagonist | |||
| 0.112 | 0.04 | 0.112 | Alpha 2 adrenoreceptor antagonist | |||
| 0.1 | 0.028 | 0.1 | Alpha adrenoreceptor agonist | |||
| 0.094 | 0.023 | 0.094 | Carbamoyl phosphate synthetase inhibitor | 0.072 0.033 CID_154699917 | ||
| 0.136 | 0.065 | 0.136 | NADPH oxidase inhibitor | |||
| 0.105 | 0.034 | 0.105 | Porphobilinogen synthase inhibitor | |||
| 0.093 | 0.022 | 0.093 | Secretase beta inhibitor | |||
| 0.089 | 0.019 | 0.089 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.082 | 0.012 | 0.082 | Potassium channel (Inward rectifier) blocker | |||
| 0.148 | 0.079 | 0.148 | CF transmembrane conductance regulator agonist | |||
| 0.144 | 0.076 | 0.144 | Hemostatic | 0.14 0.08 CID_154699917 | ||
| 0.071 | 0.004 | 0.071 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.072 | 0.005 | 0.072 | Microtubule stabilization | 0.054 0.022 CID_154699917 | ||
| 0.089 | 0.023 | 0.089 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.108 | 0.043 | 0.108 | Calcium antagonist | |||
| 0.11 | 0.046 | 0.11 | Prolactin inhibitor | |||
| 0.099 | 0.036 | 0.099 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.139 | 0.076 | 0.139 | Pregnane X receptor agonist | |||
| 0.14 | 0.077 | 0.14 | Heat shock protein 70 antagonist | |||
| 0.071 | 0.009 | 0.071 | Squalene synthetase inhibitor | |||
| 0.091 | 0.029 | 0.091 | Carbonic anhydrase VA inhibitor | |||
| 0.072 | 0.011 | 0.072 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.084 | 0.023 | 0.084 | Alcohol oxidase inhibitor | |||
| 0.087 | 0.029 | 0.087 | Vanilloid 4 agonist | |||
| 0.066 | 0.008 | 0.066 | Somatostatin 5 agonist | 0.043 0.016 CID_154699917 | ||
| 0.095 | 0.04 | 0.095 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.072 | 0.018 | 0.072 | Aconitate hydratase inhibitor | |||
| 0.122 | 0.068 | 0.122 | DNA repair enzyme inhibitor | |||
| 0.058 | 0.004 | 0.058 | Sodium/glucose cotransporter inhibitor | |||
| 0.097 | 0.044 | 0.097 | ATPase (Vacuolar H+) inhibitor | |||
| 0.086 | 0.033 | 0.086 | Carbonic anhydrase V inhibitor | |||
| 0.116 | 0.066 | 0.164 | Caspase 3 inhibitor | 0.164 0.019 CID_154699917 | CID_154699917 | |
| 0.066 | 0.016 | 0.066 | Aldosterone antagonist | |||
| 0.06 | 0.011 | 0.06 | Guanylate cyclase inhibitor | |||
| 0.076 | 0.027 | 0.076 | Argininosuccinate synthase inhibitor | |||
| 0.1 | 0.052 | 0.1 | Alcohol dehydrogenase inhibitor | |||
| 0.151 | 0.104 | 0.391 | Phospholipase C inhibitor | 0.391 0.011 CID_154699917 | CID_154699917 | |
| 0.125 | 0.077 | 0.125 | Toll-Like receptor antagonist | |||
| 0.194 | 0.147 | 0.194 | Lipoxygenase inhibitor | |||
| 0.096 | 0.049 | 0.096 | Ornithine decarboxylase inhibitor | |||
| 0.089 | 0.043 | 0.089 | Estrogen-related receptor beta agonist | |||
| 0.066 | 0.02 | 0.066 | Pregnane X receptor antagonist | |||
| 0.063 | 0.018 | 0.063 | Squalene epoxidase inhibitor | |||
| 0.156 | 0.112 | 0.354 | DNA methylase inhibitor | 0.354 0.016 CID_154699917 | CID_154699917 | |
| 0.061 | 0.018 | 0.061 | Potassium channel (Inward rectifier) activator | |||
| 0.068 | 0.025 | 0.068 | Toll-Like receptor 8 antagonist | |||
| 0.078 | 0.036 | 0.111 | Glucagon-like peptide 1 agonist | 0.111 0.017 CID_154699917 | CID_154699917 | |
| 0.098 | 0.056 | 0.098 | Phosphodiesterase 6D inhibitor | |||
| 0.106 | 0.064 | 0.106 | DOPA decarboxylase inhibitor | |||
| 0.058 | 0.018 | 0.058 | Potassium channel (ATP-sensitive) activator | |||
| 0.048 | 0.008 | 0.048 | Plasmepsin I inhibitor | 0.029 0.023 CID_154699917 | ||
| 0.063 | 0.023 | 0.063 | Alpha-mannosidase inhibitor | |||
| 0.06 | 0.022 | 0.06 | Topoisomerase II beta inhibitor | |||
| 0.047 | 0.009 | 0.047 | Tubulin agonist | |||
| 0.079 | 0.043 | 0.165 | Aminopeptidase I inhibitor | 0.165 0.01 CID_154699917 | CID_154699917 | |
| 0.066 | 0.03 | 0.066 | Alpha 1 adrenoreceptor agonist | |||
| 0.1 | 0.065 | 0.326 | Aminopeptidase B inhibitor | 0.326 0.007 CID_154699917 | CID_154699917 | |
| 0.081 | 0.048 | 0.081 | Estrogen receptor alpha antagonist | |||
| 0.096 | 0.063 | 0.096 | Electrolyte absorption antagonist | |||
| 0.048 | 0.017 | 0.048 | Kainate receptor agonist | |||
| 0.066 | 0.036 | 0.066 | Calcium channel P-type blocker | |||
| 0.185 | 0.156 | 0.185 | Transcription factor STAT3 inhibitor | |||
| 0.096 | 0.068 | 0.096 | Glutamate (mGluR7) agonist | |||
| 0.08 | 0.051 | 0.08 | Macrophage migration inhibitory factor inhibitor | |||
| 0.048 | 0.02 | 0.048 | Thymidine kinase inhibitor | |||
| 0.03 | 0.004 | 0.03 | Antibiotic Anthracycline-like | |||
| 0.051 | 0.025 | 0.051 | Mannosidase inhibitor | |||
| 0.051 | 0.026 | 0.051 | Cytokine production stimulant | |||
| 0.05 | 0.026 | 0.05 | Adenylate cyclase 1 inhibitor | |||
| 0.042 | 0.017 | 0.042 | Fumarate hydratase inhibitor | |||
| 0.037 | 0.013 | 0.037 | Uridine phosphorylase inhibitor | |||
| 0.103 | 0.079 | 0.103 | Acetylcholine release stimulant | |||
| 0.066 | 0.042 | 0.078 | Protease 3C (Human rhinovirus) inhibitor | 0.078 0.029 CID_154699917 | CID_154699917 | |
| 0.074 | 0.05 | 0.271 | Glutamate decarboxylase inhibitor | 0.271 0.004 CID_154699917 | CID_154699917 | |
| 0.045 | 0.022 | 0.045 | Heme oxygenase inhibitor | |||
| 0.045 | 0.022 | 0.045 | Dopamine D5 agonist | |||
| 0.104 | 0.082 | 0.159 | Proteasome inhibitor | 0.159 0.041 CID_154699917 | CID_154699917 | |
| 0.054 | 0.033 | 0.054 | Estrogen agonist | |||
| 0.165 | 0.144 | 0.165 | ErbB-1 antagonist | |||
| 0.071 | 0.05 | 0.071 | Phospholipase D inhibitor | |||
| 0.037 | 0.016 | 0.037 | ATP citrate lysase inhibitor | |||
| 0.06 | 0.039 | 0.06 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.138 | 0.118 | 0.307 | DNA methyltransferase I inhibitor | 0.307 0.024 CID_154699917 | CID_154699917 | |
| 0.098 | 0.078 | 0.098 | 5 Hydroxytryptamine 3A agonist | |||
| 0.071 | 0.052 | 0.071 | Epoxide hydrolase inhibitor | |||
| 0.116 | 0.097 | 0.131 | Vanilloid 1 agonist | 0.131 0.065 CID_154699917 | CID_154699917 | |
| 0.042 | 0.023 | 0.042 | Alpha 1d adrenoreceptor agonist | |||
| 0.082 | 0.063 | 0.082 | D-Ala-D-Ala ligase inhibitor | |||
| 0.05 | 0.031 | 0.05 | Adenosine deaminase inhibitor | 0.041 0.039 CID_154699917 | ||
| 0.076 | 0.058 | 0.076 | MAP kinase kinase 7 inhibitor | |||
| 0.039 | 0.021 | 0.039 | Estrogen receptor alpha agonist | |||
| 0.139 | 0.121 | 0.139 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.027 | 0.009 | 0.027 | Imidazoline I1 receptor antagonist | |||
| 0.027 | 0.008 | 0.027 | Isoleucine-tRNA ligase inhibitor | |||
| 0.032 | 0.014 | 0.032 | Purinergic P2Y15 antagonist | |||
| 0.082 | 0.064 | 0.082 | Histamine N-methyltransferase inhibitor | |||
| 0.029 | 0.011 | 0.029 | Vanilloid 2 agonist | |||
| 0.232 | 0.215 | 0.232 | MAP kinase kinase 6 inhibitor | |||
| 0.09 | 0.073 | 0.09 | Sphingomyelinase inhibitor | |||
| 0.039 | 0.022 | 0.039 | Antibiotic Aminoglycoside-like | |||
| 0.058 | 0.043 | 0.058 | Aromatase inhibitor | |||
| 0.039 | 0.024 | 0.039 | Glutamate (mGluR8) agonist | |||
| 0.084 | 0.07 | 0.173 | Aminoacyl-tRNA synthetase inhibitor | 0.173 0.014 CID_154699917 | CID_154699917 | |
| 0.064 | 0.051 | 0.064 | Acetylcholine M5 receptor agonist | |||
| 0.058 | 0.045 | 0.058 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.055 | 0.042 | 0.055 | Fatty acid synthase inhibitor | |||
| 0.046 | 0.033 | 0.046 | Carbonic anhydrase VII inhibitor | |||
| 0.04 | 0.028 | 0.04 | CF transmembrane conductance regulator antagonist | |||
| 0.078 | 0.067 | 0.078 | Thioredoxin reductase inhibitor | |||
| 0.057 | 0.046 | 0.057 | Alpha 2 adrenoreceptor agonist | |||
| 0.038 | 0.027 | 0.038 | Vanilloid 3 antagonist | |||
| 0.019 | 0.008 | 0.019 | Telomerase stimulant | |||
| 0.024 | 0.013 | 0.024 | Prostaglandin F2 alpha agonist | |||
| 0.015 | 0.004 | 0.015 | Progesterone receptor A antagonist | |||
| 0.055 | 0.045 | 0.055 | Leukotriene C antagonist | |||
| 0.027 | 0.017 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.035 | 0.027 | 0.035 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.07 | 0.061 | 0.07 | Topoisomerase II alpha inhibitor | |||
| 0.048 | 0.039 | 0.058 | Lysophosphatidic acid 3 receptor antagonist | 0.058 0.024 CID_154699917 | CID_154699917 | |
| 0.017 | 0.009 | 0.017 | NMDA receptor phencyclidine site antagonist | |||
| 0.044 | 0.036 | 0.071 | Antimetabolite | 0.071 0.021 CID_154699917 | CID_154699917 | |
| 0.063 | 0.055 | 0.063 | Potassium channel (ATP-sensitive) blocker | |||
| 0.146 | 0.139 | 0.146 | Potassium channel blocker | |||
| 0.164 | 0.157 | 0.242 | Calpain inhibitor | 0.242 0.073 CID_154699917 | CID_154699917 | |
| 0.033 | 0.026 | 0.033 | Retinoid X alpha receptor agonist | |||
| 0.108 | 0.101 | 0.108 | Antibacterial (Helicobacter pylori) | |||
| 0.039 | 0.032 | 0.039 | Plasmepsin II inhibitor | |||
| 0.021 | 0.015 | 0.021 | Adenosine kinase inhibitor | |||
| 0.012 | 0.006 | 0.012 | Imidazoline I2 receptor antagonist | |||
| 0.114 | 0.107 | 0.114 | Cytidine deaminase inhibitor | |||
| 0.04 | 0.033 | 0.04 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.039 | 0.033 | 0.056 | Growth hormone release inhibitor | 0.056 0.018 CID_154699917 | CID_154699917 | |
| 0.139 | 0.133 | 0.175 | Neurotensin receptor agonist | 0.175 0.055 CID_154699917 | CID_154699917 | |
| 0.024 | 0.019 | 0.024 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.051 | 0.046 | 0.051 | Sphingosine kinase 2 inhibitor | |||
| 0.054 | 0.05 | 0.054 | Androgen agonist | |||
| 0.049 | 0.045 | 0.049 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.068 | 0.063 | 0.068 | Orexin receptor 1 antagonist | |||
| 0.014 | 0.01 | 0.014 | Antibiotic Macrolide-like | |||
| 0.056 | 0.052 | 0.056 | Ryanodine receptor antagonist | |||
| 0.044 | 0.04 | 0.044 | Cholesterol esterase inhibitor | |||
| 0.013 | 0.01 | 0.013 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.094 | 0.09 | 0.094 | Multidrug resistance-associated protein 1 inhibitor | |||
| 0.036 | 0.033 | 0.036 | Dopamine D3 agonist | |||
| 0.026 | 0.023 | 0.026 | Hedgehog signaling activator | |||
| 0.086 | 0.084 | 0.086 | Bile acid receptor antagonist | |||
| 0.017 | 0.016 | 0.017 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.019 | 0.018 | 0.019 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.031 | 0.03 | 0.081 | Arginase inhibitor | 0.081 0.005 CID_154699917 | CID_154699917 | |
| 0.045 | 0.045 | 0.123 | Ornithine carbamoyltransferase inhibitor | 0.123 0.012 CID_154699917 | CID_154699917 | |
| 0.044 | 0.045 | 0.05 | HCV NS3/NS4A protease inhibitor | 0.05 0.032 CID_154699917 | CID_154699917 | |
| 0.073 | 0.075 | 0.461 | Glutathione S-transferase inhibitor | 0.461 0.002 CID_154699917 | CID_154699917 | |
| 0.146 | 0.15 | 0.321 | Platelet antagonist | 0.321 0.046 CID_154699917 | CID_154699917 | |
| 0.06 | 0.065 | 0.182 | Catalase inhibitor | 0.182 0.019 CID_154699917 | CID_154699917 | |
| 0.099 | 0.106 | 0.265 | Toll-Like receptor 2 antagonist | 0.265 0.007 CID_154699917 | CID_154699917 | |
| 0.128 | 0.139 | 0.492 | Interleukin antagonist | 0.492 0.02 CID_154699917 | CID_154699917 | |
| 0.03 | 0.049 | 0.051 | Membrane dipeptidase inhibitor | 0.051 0.015 CID_154699917 | CID_154699917 | |
| 0.066 | 0.091 | 0.076 | Inducible nitric-oxide synthase inhibitor | 0.076 0.069 CID_154699917 | CID_154699917 | |
| 0.104 | 0.135 | 0.141 | Protein-tyrosine phosphatase inhibitor | 0.141 0.089 CID_154699917 | CID_154699917 | |
| 0.007 | 0.041 | 0.02 | Ileal bile acid transport inhibitor | 0.02 0.009 CID_154699917 | CID_154699917 | |
| 0.116 | 0.15 | 0.148 | Platelet adhesion inhibitor | 0.148 0.108 CID_154699917 | CID_154699917 | |
| 0.171 | 0.207 | 0.321 | Insulysin inhibitor | 0.321 0.047 CID_154699917 | CID_154699917 | |
| 0.021 | 0.058 | 0.05 | Kinesin-like protein 1 inhibitor | 0.05 0.016 CID_154699917 | CID_154699917 | |
| 0.021 | 0.058 | 0.05 | Kinesin antagonist | 0.05 0.016 CID_154699917 | CID_154699917 | |
| 0.041 | 0.078 | 0.071 | Carbonic anhydrase stimulant | 0.071 0.031 CID_154699917 | CID_154699917 | |
| 0.023 | 0.063 | 0.035 | Carboxypeptidase B inhibitor | 0.035 0.02 CID_154699917 | CID_154699917 | |
| 0.023 | 0.064 | 0.201 | Toll-Like receptor 2 agonist | 0.201 0.007 CID_154699917 | CID_154699917 | |
| 0.107 | 0.15 | 0.26 | Thiol protease inhibitor | 0.26 0.024 CID_154699917 | CID_154699917 | |
| 0.099 | 0.147 | 0.276 | Phospholipase A2 inhibitor | 0.276 0.017 CID_154699917 | CID_154699917 | |
| 0.006 | 0.054 | 0.022 | Aminopeptidase A inhibitor | 0.022 0.009 CID_154699917 | CID_154699917 | |
| 0.069 | 0.12 | 0.097 | Protein-tyrosine phosphatase 1B inhibitor | 0.097 0.081 CID_154699917 | CID_154699917 | |
| 0.013 | 0.067 | 0.033 | Lysine carboxypeptidase inhibitor | 0.033 0.014 CID_154699917 | CID_154699917 | |
| 0.025 | 0.082 | 0.045 | Thymidylate synthase inhibitor | 0.045 0.034 CID_154699917 | CID_154699917 | |
| 0.024 | 0.081 | 0.099 | Ribonucleoside-diphosphate reductase inhibitor | 0.099 0.019 CID_154699917 | CID_154699917 | |
| 0.023 | 0.082 | 0.098 | Ribonucleotide reductase inhibitor | 0.098 0.021 CID_154699917 | CID_154699917 | |
| 0.041 | 0.102 | 0.066 | NMDA receptor agonist | 0.066 0.04 CID_154699917 | CID_154699917 | |
| 0.033 | 0.106 | 0.05 | Bombesin 2 receptor antagonist | 0.05 0.034 CID_154699917 | CID_154699917 | |
| 0.026 | 0.103 | 0.055 | Cathepsin L inhibitor | 0.055 0.044 CID_154699917 | CID_154699917 | |
| 0.013 | 0.102 | 0.024 | Calcium-sensing receptor agonist | 0.024 0.023 CID_154699917 | CID_154699917 | |
| 0.165 | 0.26 | 0.353 | Interleukin 2 agonist | 0.353 0.044 CID_154699917 | CID_154699917 | |
| 0.03 | 0.127 | 0.086 | Nitric oxide donor | 0.086 0.018 CID_154699917 | CID_154699917 | |
| 0.019 | 0.126 | 0.054 | Metalloproteinase-3 inhibitor | 0.054 0.029 CID_154699917 | CID_154699917 | |
| 0.064 | 0.176 | 0.148 | Toll-Like receptor 4 antagonist | 0.148 0.022 CID_154699917 | CID_154699917 | |
| 0.038 | 0.159 | 0.098 | Metalloproteinase-2 inhibitor | 0.098 0.039 CID_154699917 | CID_154699917 | |
| 0.022 | 0.167 | 0.053 | Matrix metalloproteinase (membrane-type) inhibitor | 0.053 0.041 CID_154699917 | CID_154699917 | |
| 0.035 | 0.184 | 0.082 | Adenine nucleotide translocase inhibitor | 0.082 0.008 CID_154699917 | CID_154699917 | |
| 0.033 | 0.197 | 0.077 | Metalloproteinase-9 inhibitor | 0.077 0.047 CID_154699917 | CID_154699917 | |
| 0.051 | 0.215 | 0.114 | Transcription factor NF kappa B stimulant | 0.114 0.028 CID_154699917 | CID_154699917 | |
| 0.061 | 0.238 | 0.102 | Cell adhesion inhibitor | 0.102 0.086 CID_154699917 | CID_154699917 | |
| 0.021 | 0.204 | 0.079 | Matrix metalloproteinase inhibitor | 0.079 0.038 CID_154699917 | CID_154699917 | |
| 0.013 | 0.199 | 0.086 | Neutrophil collagenase inhibitor | 0.086 0.028 CID_154699917 | CID_154699917 | |
| 0.012 | 0.209 | 0.068 | Glycine transporter 2 inhibitor | 0.068 0.022 CID_154699917 | CID_154699917 | |
| 0.02 | 0.241 | 0.051 | Cathepsin F inhibitor | 0.051 0.012 CID_154699917 | CID_154699917 | |
| 0.029 | 0.271 | 0.134 | Protease inhibitor | 0.134 0.038 CID_154699917 | CID_154699917 | |
| 0.032 | 0.291 | 0.073 | Chymotrypsin inhibitor | 0.073 0.065 CID_154699917 | CID_154699917 | |
| 0.016 | 0.311 | 0.044 | Glutamate (mGluR8) antagonist | 0.044 0.012 CID_154699917 | CID_154699917 | |
| 0.062 | 0.365 | 0.33 | Growth hormone agonist | 0.33 0.027 CID_154699917 | CID_154699917 | |
| 0.027 | 0.398 | 0.327 | Thrombolytic | 0.327 0.02 CID_154699917 | CID_154699917 | |
| 0.003 | 0.395 | 0.023 | Aminopeptidase P inhibitor | 0.023 0.016 CID_154699917 | CID_154699917 | |
| 0.019 | 0.488 | 0.158 | Chelator | 0.158 0.033 CID_154699917 | CID_154699917 | |
| 0.058 | 0.538 | 0.524 | Immunomodulator | 0.524 0.02 CID_154699917 | CID_154699917 | |
| 0.004 | 0.515 | 0.046 | Purinergic P2Y12 antagonist | 0.046 0.007 CID_154699917 | CID_154699917 | |
| 0.005 | 0.52 | 0.038 | Macrophage elastase inhibitor | 0.038 0.036 CID_154699917 | CID_154699917 | |
| 0.058 | 0.582 | 0.411 | Sodium/bile acid cotransporter inhibitor | 0.411 0.014 CID_154699917 | CID_154699917 | |
| 0.017 | 0.549 | 0.083 | Somatostatin 1 agonist | 0.083 0.048 CID_154699917 | CID_154699917 | |
| 0.015 | 0.576 | 0.058 | Trypsin inhibitor | 0.058 0.053 CID_154699917 | CID_154699917 | |
| 0.004 | 0.599 | 0.048 | Collagenase inhibitor | 0.048 0.037 CID_154699917 | CID_154699917 | |
| 0.01 | 0.616 | 0.042 | Neurokinin 2 agonist | 0.042 0.027 CID_154699917 | CID_154699917 | |
| 0.004 | 0.613 | 0.085 | Angiotensin-converting enzyme inhibitor | 0.085 0.012 CID_154699917 | CID_154699917 | |
| 0.003 | 0.64 | 0.167 | Leukotriene A4 hydrolase inhibitor | 0.167 0.005 CID_154699917 | CID_154699917 | |
| 0.002 | 0.664 | 0.022 | Neutral endopeptidase inhibitor | 0.022 0.014 CID_154699917 | CID_154699917 | |
| 0.037 | 0.714 | 0.149 | Factor V inhibitor | 0.149 0.019 CID_154699917 | CID_154699917 | |
| 0.008 | 0.701 | 0.043 | Cholecystokinin B agonist | 0.043 0.021 CID_154699917 | CID_154699917 | |
| 0.014 | 0.717 | 0.057 | Carbonic anhydrase II stimulant | 0.057 0.028 CID_154699917 | CID_154699917 | |
| 0.003 | 0.71 | 0.054 | Complement C3a chemotactic receptor antagonist | 0.054 0.025 CID_154699917 | CID_154699917 | |
| 0.011 | 0.734 | 0.103 | Factor XII inhibitor | 0.103 0.035 CID_154699917 | CID_154699917 | |
| 0.006 | 0.753 | 0.063 | Cathepsin B inhibitor | 0.063 0.033 CID_154699917 | CID_154699917 | |
| 0.005 | 0.756 | 0.045 | Endothelin-converting enzyme inhibitor | 0.045 0.034 CID_154699917 | CID_154699917 | |
| 0.007 | 0.759 | 0.043 | Bombesin antagonist | 0.043 0.042 CID_154699917 | CID_154699917 | |
| 0.021 | 0.798 | 0.211 | Hematopoietic | 0.211 0.009 CID_154699917 | CID_154699917 | |
| 0.027 | 0.808 | 0.119 | Folate antagonist | 0.119 0.04 CID_154699917 | CID_154699917 | |
| 0.003 | 0.793 | 0.03 | Bradykinin B2 receptor agonist | 0.03 0.018 CID_154699917 | CID_154699917 | |
| 0.009 | 0.803 | 0.118 | Bone formation stimulant | 0.118 0.087 CID_154699917 | CID_154699917 | |
| 0.006 | 0.8 | 0.053 | Erythropoietin receptor agonist | 0.053 0.02 CID_154699917 | CID_154699917 | |
| 0.01 | 0.806 | 0.059 | Bombesin 1 receptor agonist | 0.059 0.042 CID_154699917 | CID_154699917 | |
| 0.008 | 0.808 | 0.084 | Sirtuin 1 inhibitor | 0.084 0.032 CID_154699917 | CID_154699917 | |
| 0.004 | 0.816 | 0.055 | Aminopeptidase N inhibitor | 0.055 0.027 CID_154699917 | CID_154699917 | |
| 0.013 | 0.834 | 0.104 | Nav1.4 sodium channel blocker | 0.104 0.071 CID_154699917 | CID_154699917 | |
| 0.005 | 0.834 | 0.075 | Aminopeptidase microsomal inhibitor | 0.075 0.027 CID_154699917 | CID_154699917 | |
| 0.012 | 0.844 | 0.184 | Histone deacetylase SIRT1 inhibitor | 0.184 0.037 CID_154699917 | CID_154699917 | |
| 0.004 | 0.847 | 0.042 | Carbonic anhydrase I stimulant | 0.042 0.022 CID_154699917 | CID_154699917 | |
| 0.002 | 0.851 | 0.055 | GP IIb/IIIa receptor antagonist | 0.055 0.03 CID_154699917 | CID_154699917 | |
| 0.005 | 0.861 | 0.224 | Anticoagulant | 0.224 0.045 CID_154699917 | CID_154699917 | |
| 0.003 | 0.878 | 0.034 | Protocollagen prolyl hydroxylase inhibitor | 0.034 0.011 CID_154699917 | CID_154699917 | |
| 0.005 | 0.902 | 0.117 | Histone deacetylase class III inhibitor | 0.117 0.072 CID_154699917 | CID_154699917 | |
| 0.004 | 0.903 | 0.067 | Thrombin inhibitor | 0.067 0.059 CID_154699917 | CID_154699917 | |
| 0.005 | 0.918 | 0.043 | Neurotensin receptor antagonist | 0.043 0.034 CID_154699917 | CID_154699917 | |
| 0.003 | 0.972 | 0.041 | Integrin alpha5beta1 antagonist | 0.041 0.028 CID_154699917 | CID_154699917 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |